Echinomycin and a novel analogue induce apoptosis of HT-29 cells via the activation of MAP kinases pathway

Pharmacological Research

Volumn 50, Issue 2, 2004, Pages 201-207

  Park, Ju Youn ^a   Park, Su Jung ^a   Shim, Kwang Yong ^a   Lee, Kyu Jae ^a   Kim, Yun Bong ^b   Kim, Yong Hae ^b   Kim, Soo Kie ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Apoptosis; Echinomycin; HT 291; MAP kinases; YK 2000

Indexed keywords

ANTINEOPLASTIC AGENT; ECHINOMYCIN; ECHINOMYCIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ARGININE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; YK 2000;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HT29; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CYTOLOGICAL TECHNIQUES; DNA FRAGMENTATION; ECHINOMYCIN; FORECASTING; FORMAZANS; HT29 CELLS; HUMANS; KOREA; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; TETRAZOLIUM SALTS;

EID: 2942625973     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2004.01.005     Document Type: Article

References (35)

1. Arita D., Kambe M., Ishioka C., Kanamaru R. Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn. J. Cancer Res. 88:1997;39-43
2. Peters G.J., Wilt C.L., Moorsel C.J., Kroep J.R., Bergman A.M., Ackland S.P. Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol. Ther. 87:2000;227-253
3. Kaufmann S.H., Earnshaw W. Induction of apoptosis by cancer chemotherapy. Exp. Cell. Res. 256:2000;42-49
4. Muss H.B., Blessing J.A., Baker V.V., Barnhill D.R., Adelson M.D. Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group. Am. J. Clin. Oncol. 13:1990;299-301
5. Fletcher M.C., Fox K.R. Dissociation kinetics of echinomycin from CpG binding sites in different sequence environments. Biochemistry. 35:1996;1064-1075
6. Park Y.S., Kim Y.H., Kim S.K., Choi S.J. A new antitumor agent: methyl sulfonium perchlorate of echinomycin. Bioorg. Med. Chem. Lett. 8:1998;731-734
7. Kim S.K., Ahn C.M., Kim T.U., Choi S.J., Park Y.S., Shin W.S., et al. In vitro chemosensitivity test of SK-302 on human colon carcinoma cell lines. Arch. Pharm. Res. 19:1996;261-263
8. Kim T.U., Yang S., Kim S.K. Cytotoxic and apoptotic effects of echinomycin on murine leukemia cells. J. Biochem. Mol. Biol. 29:1996;489-492
9. Jeon H., Kim S.S., Kim Y.S., Park Y.S., Kim Y.H., Choi S.J., et al. Cytotoxic and apoptotic activities of echinomycin derivative (Echinomycin-7) on P388 murine leukemia cells. J. Biochem. Mol. Biol. 131:1998;560-564
10. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:1989;5870-5878
11. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985
12. Gardner A.M., Johnson G.L. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 273:1996;4928-4936
13. Collett E.D., Davidson L.A., Fan Y.Y., Lupton J.R., Chapkin R.S. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes Am. J. Physiol. Cell Physiol. 280:2001;1066-1075
14. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 81:1995;1137-1146
15. Saleem A., Datta R., Yuan Z.M., Kharbanda S., Kufe D. Involvement of stress-activated protein kinase in the cellular response to 1-beta-D- arabinofuranosylcytosine and other DNA-damaging agents. Cell Growth Differ. 6:1995;1651-1658
16. Zanke B.W., Boudreau K., Rubie E., Winnett E., Tibbles L.A., Zon L., et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6:1996;606-613
17. Bernges F., Burkle A., Kupper J.H., Zeller W.J. Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells. Carcinogenesis. 18:1997;663-668
18. Janicke R., Ng P., Sprengart M., Porter A. Caspase-3 is required for-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:1998;15540-15545
19. Le Rhun Y., Kirkland J., Shah G. Cellular responses to DNA damage in the absence of poly(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 245:1998;1-10
20. Chen H., Patel D.J. Solution structure of a quinomycin bisintercalator-DNA complex. J. Mol. Biol. 246:1995;164-179
21. Gao X.L., Patel D.J. NMR studies of echinomycin bisintercalation complexes with d(A1-C2-G3-T4) and d(T1-C2-G3-A4) duplexes in aqueous solution: sequence-dependent formation of Hoogsteen A1.T4 and Watson-Crick T1.A4 base pairs flanking the bisintercalation site. Biochemistry. 27:1998;1744-1751
22. Cobb W.R., Bogden A.E., Reich S.D., Griffin T.W., Kelton D.E., LePage D.J. Activity of two phase I drugs N-methylformamide (NSC-3051), Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assay. Invest. New Drugs. 1:1983;5-9
23. Herbert J.M., Lale A., Pereillo J.M., Derocq J.M., Casellas P. Echinomycin suppresses the pyrogenic effects of endotoxin and interleukin-1 beta in human endothelial cells and peripheral blood mononuclear cells. Thromb. Haemost. 75:1996;359-362
24. Mollegaard N.E., Bailly C., Waring M.J., Nielsen P.E. Quinoxaline antibiotics enhance peptide nucleic acid binding to double-stranded DNA. Biochemistry. 39:2000;9502-9507
25. Wu C.H., Jeng J.H., Wang Y.J., Tseng C.J., Liang Y.C., Chen C.H., et al. Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest. Toxicol.Appl. Pharmacol. 180:2002;22-35
26. Kleeff J., Kornmann M., Sawhney H., Korc M. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int. J. Cancer. 86:2000;399-407
27. Thrane E.V., Refsnes M., Thoresen G.H., Lag M., Schwarze P.E. Fluoride-induced apoptosis in epithelial lung cells involves activation of MAP kinases p38 and possibly JNK. Toxicol. Sci. 61:2001;83-91
28. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61:2001;1604-1610
29. Qiao D., Stratagouleas E.D., Martinez J.D. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis. 22:2001;35-41
30. Stadheim T.A., Kucera G.L. c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells. Leuk. Res. 26:2002;55-65
31. Basu S., Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 17:1998;3277-3285
32. Chuang S.M., Wang I.C., Yang J.L. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis. 21:2000;1423-1432
33. Hardwick J.C., Brink G.R., Offerhaus G.J., Deventer S.J., Peppelenbosch M.P. NF-kappaB, p38 MAP kinase and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene. 20:2001;819-827
34. Montaner B., Perez-Tomas R. The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK. Toxicol. Lett. 24:2002;93-98
35. Ding Q., Wang Q., Evers B.M. Alterations of MAP kinase activities associated with intestinal cell differentiation. Biochem. Biophys. Res. Commun. 284:2001;282-288